Gynecological Disorders Practice Questions

Q: What is the shape of the external os in a nulliparous female?

Circular. **Explanation:** The shape of the external os is a classic clinical indicator used to distinguish between a woman who has undergone vaginal childbirth and one who has not. **1. Why Circular is Correct:** In a **nulliparous** female (one who has never given birth), the external os is a small, smooth, and **circular** (or pin-head) opening. This is the anatomical state of the cervix before it has been subjected to the significant stretching and inevitable minor lacerations that occur during the second stage of labor. **2. Analysis of Incorrect Options:** * **B. Transverse:** This is the characteristic shape in a **multiparous** female. Following vaginal delivery, the circular os stretches and typically sustains small lateral tears. Once healed, the os appears as a wide, horizontal, or **transverse slit**. * **C. Vesicular:** This is not a standard anatomical description for the cervical os. The term "vesicular" usually refers to fluid-filled sacs (e.g., a hydatidiform mole). * **D. Oval:** While the os may appear slightly oval in some nulliparous women, "circular" is the standard medical descriptor used in textbooks and competitive exams like NEET-PG. **High-Yield Clinical Pearls for NEET-PG:** * **Nulliparous:** Circular/Pin-head os. * **Multiparous:** Transverse slit/Stellate (if severely lacerated). * **Ectocervix Lining:** Stratified squamous epithelium. * **Endocervix Lining:** Simple columnar epithelium. * **The Transformation Zone:** The area between the original and new squamocolumnar junction; it is the most common site for cervical intraepithelial neoplasia (CIN) and cervical cancer.

Q: What is the surest sign of salpingitis?

Seropurulent discharge from the fallopian tubes. **Explanation:** Salpingitis, a key component of Pelvic Inflammatory Disease (PID), is characterized by inflammation of the fallopian tubes. While several visual changes occur during laparoscopy, the **surest (most pathognomonic) sign** is the presence of **seropurulent discharge** (pus) leaking from the fimbrial ends or the tubal surface. **Why Option C is correct:** The presence of purulent or seropurulent exudate is the definitive evidence of active bacterial infection and inflammation within the tubal lumen. While other signs indicate inflammation, the visualization of pus is the most specific indicator that confirms the diagnosis of acute salpingitis during a laparoscopic evaluation. **Why other options are incorrect:** * **Options A, B, and D (Edema, Enlargement, and Hyperemia):** These are common features of inflammation, but they are **non-specific**. They can be seen in other conditions such as pelvic congestion syndrome, torsion, or even physiological changes during the periovulatory phase. While they are sensitive markers for inflammation, they lack the specificity of purulent discharge. **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Laparoscopy is the gold standard for diagnosing PID/salpingitis. * **Minimum Clinical Criteria (CDC):** For bedside diagnosis, the triad includes: 1) Cervical motion tenderness, 2) Uterine tenderness, and 3) Adnexal tenderness. * **Most Common Organisms:** *Chlamydia trachomatis* (most common overall) and *Neisseria gonorrhoeae*. * **Complications:** Chronic salpingitis is a leading cause of ectopic pregnancy and tubal factor infertility due to the destruction of the endosalpinx and subsequent scarring.

Q: All of the following can be used in the medical management of fibroid uterus EXCEPT?

Danazol. **Explanation:** The medical management of uterine fibroids (leiomyomas) aims to reduce heavy menstrual bleeding (HMB) and/or shrink the size of the tumors. **Why Danazol is the correct answer:** While **Danazol** is an androgenic steroid that creates a high-androgen, low-estrogen environment, it is **no longer recommended** or used for fibroids due to its significant androgenic side effects (weight gain, hirsutism, acne) and lack of proven efficacy in reducing fibroid volume compared to newer alternatives. It is primarily used in endometriosis or hereditary angioedema. **Analysis of other options:** * **Mifepristone (Option A):** A Selective Progesterone Receptor Modulator (SPRM). Since fibroid growth is progesterone-dependent, mifepristone effectively reduces both fibroid volume and HMB. * **NSAIDs (Option B):** These are used as first-line symptomatic management to reduce dysmenorrhea and blood loss by inhibiting prostaglandin synthesis, though they do not reduce the size of the fibroid. * **Leuprolide (Option C):** A GnRH agonist that induces a state of "pseudomenopause." It is highly effective in shrinking fibroids (up to 50% reduction) and is often used preoperatively to correct anemia and facilitate surgery. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Medical Management:** GnRH agonists (e.g., Leuprolide, Goserelin) are the most effective for volume reduction but are limited to 6 months of use due to bone mineral density loss. * **Ulipristal Acetate:** Another SPRM frequently tested; it is highly effective for preoperative volume reduction. * **Levonorgestrel-IUS (Mirena):** Excellent for controlling HMB associated with fibroids, provided the uterine cavity is not significantly distorted. * **Definitive Treatment:** Hysterectomy remains the only definitive cure for symptomatic fibroids.

Q: Pain in endometriosis is due to all except:

Retroversion of uterus. **Explanation:** The pain associated with endometriosis is complex and multifactorial, primarily driven by biochemical and structural changes within the pelvic environment. **Why "Retroversion of uterus" is the correct answer:** Retroversion of the uterus is a common anatomical variation found in approximately 20% of the general population and is typically asymptomatic. While endometriosis can cause a "fixed" retroverted uterus due to adhesions (especially in the Pouch of Douglas), the retroversion itself is a **consequence** or a physical finding, not the underlying physiological mechanism of pain. **Analysis of other options (Mechanisms of pain):** * **Inflammatory cytokines (Option A):** Endometriotic lesions act as local inflammatory foci. They produce high levels of prostaglandins (PGE2), interleukins, and TNF-alpha, which sensitize nociceptors and cause chronic pelvic pain. * **Focal bleeding (Option B):** Ectopic endometrial tissue undergoes cyclical proliferation and shedding. Since this blood is trapped within the peritoneal cavity or ovaries (chocolate cysts), it causes chemical peritonitis and stretching of the organ capsules, leading to acute-on-chronic pain. * **Infiltration of nerves (Option C):** Deep Infiltrating Endometriosis (DIE) often involves the uterosacral ligaments and pelvic floor. The implants can directly invade nerve fibers or cause "neuroangiogenesis," where new nerve endings grow into the lesions, leading to severe dyspareunia and chronic pain. **Clinical Pearls for NEET-PG:** * **Classic Triad:** Dysmenorrhea (congestive/secondary), Dyspareunia, and Infertility. * **Gold Standard Diagnosis:** Laparoscopy with biopsy ("Powder-burn" or "Gunshot" lesions). * **Pain Correlation:** The severity of pain in endometriosis does **not** always correlate with the stage of the disease (Revised ASRM staging). Small, active red lesions often produce more pain than large, burnt-out scars.

Q: Which type of fibroid is most commonly associated with malignancy?

Intramural. **Explanation:** **1. Why Intramural is Correct:** Uterine leiomyomas (fibroids) are benign smooth muscle tumors. While the risk of malignant transformation into a **Leiomyosarcoma (LMS)** is extremely low (approximately 0.2–0.5%), when it does occur, it most frequently arises from an **intramural fibroid**. This is primarily due to the fact that intramural fibroids are the **most common anatomical type** overall. Since they represent the largest pool of fibroid tissue, they statistically account for the majority of cases where sarcomatous changes are identified. **2. Analysis of Incorrect Options:** * **Submucosal (A):** These are located just beneath the endometrium. While they are the most symptomatic (causing heavy menstrual bleeding and infertility), they are less common than intramural types and thus less frequently associated with malignancy. * **Ovarian (C):** Fibroids are tumors of the uterine smooth muscle (myometrium). While "thecoma" or "fibroma" can occur in the ovary, a "leiomyoma" is primarily a uterine pathology. Ovarian involvement is rare and usually secondary (parasitic). * **Subserosal (D):** These grow on the outer surface of the uterus. While they can reach large sizes, they are statistically less common than intramural fibroids. **3. NEET-PG High-Yield Pearls:** * **Most common type of fibroid:** Intramural. * **Most symptomatic type:** Submucosal (causes HMB/AUB). * **Red Flag for Malignancy:** Rapid increase in size of a fibroid in a **postmenopausal** woman. * **Degenerations:** The most common degeneration is **hyaline**; the most common during pregnancy is **red degeneration** (necrobiosis). * **Standard Investigation:** Transvaginal Ultrasound (TVS) is the initial investigation of choice.

Q: Which among the following is the commonest site of genital tuberculosis in women?

Tubes. **Explanation:** Genital tuberculosis (GTB) is a significant cause of chronic pelvic inflammatory disease and infertility in developing countries. It is almost always **secondary** to a primary focus elsewhere in the body (usually lungs or lymph nodes), reaching the genital tract primarily via **hematogenous spread**. **1. Why Tubes are the Correct Answer:** The **Fallopian tubes** are the most common site of involvement, affected in **90–100%** of cases. The infection typically starts in the endosalpinx and spreads to other pelvic organs. The tubes are usually affected bilaterally, leading to characteristic findings like "lead pipe" appearance or "tobacco pouch" appearance, which often results in tubal factor infertility. **2. Why Other Options are Incorrect:** * **Uterus (Endometrium):** This is the second most common site, involved in **50–60%** of cases. It is usually secondary to descending spread from the tubes. * **Ovaries:** Involved in about **20–30%** of cases, typically as a perioophoritis. * **Cervix:** A relatively rare site, involved in only **5–15%** of cases. It may mimic cervical malignancy on examination. * **Vagina/Vulva:** These are the rarest sites (approx. **1%**), usually occurring due to direct inoculation or infected discharge from higher up in the tract. **Clinical Pearls for NEET-PG:** * **Order of Frequency:** Fallopian Tubes (100%) > Endometrium (50%) > Ovaries (25%) > Cervix (5%). * **Most Common Symptom:** Infertility (often primary) followed by menstrual irregularities (most commonly oligomenorrhea or amenorrhea). * **Gold Standard Diagnosis:** Endometrial biopsy/aspirate for **histopathology** (showing giant cells/granulomas) and **TB Culture** (Lowenstein-Jensen medium). * **HSG Finding:** "Beaded tube" appearance or "Rosary bead" appearance due to multiple strictures.

Q: Which of the following drugs is not used for pain management in endometriosis?

Methotrexate. **Explanation:** The primary goal of pain management in endometriosis is to induce a hypoestrogenic state or cause decidualization of the ectopic endometrial tissue, as the disease is estrogen-dependent. **Why Methotrexate is the Correct Answer:** **Methotrexate** is a folic acid antagonist that inhibits DNA synthesis. It is primarily used in the management of **ectopic pregnancy** (to destroy rapidly dividing trophoblastic tissue) and in certain autoimmune conditions or malignancies. It has no role in the hormonal modulation required to treat endometriosis and is not used for its pain management. **Analysis of Incorrect Options:** * **Oral Contraceptive Pills (OCPs):** These are considered **first-line** therapy. They work by inducing a pseudopregnancy state, leading to decidualization and eventual atrophy of the endometrial implants. * **GnRH Agonists (e.g., Leuprolide):** These create a state of **pseudomenopause**. Continuous administration causes downregulation of pituitary GnRH receptors, leading to low FSH/LH and profound hypoestrogenism, which shrinks the lesions. * **Mifepristone:** This is a selective progesterone receptor modulator (SPRM). It inhibits ovulation and causes direct endometrial atrophy, effectively reducing endometriosis-associated pain in refractory cases. **High-Yield Clinical Pearls for NEET-PG:** * **First-line medical treatment:** NSAIDs and OCPs. * **Gold Standard for Diagnosis:** Laparoscopy (visualizing "powder-burn" or "mulberry" lesions). * **Add-back therapy:** When using GnRH agonists for >6 months, low-dose estrogen/progesterone must be added to prevent bone mineral density loss and vasomotor symptoms. * **Danazol:** An older treatment that creates a "pseudomenopause" state but is rarely used now due to androgenic side effects (hirsutism, acne).

Q: All of the following are used in the treatment of endometriosis except:

Tibolone. The goal of medical management in endometriosis is to induce a **"pseudopregnancy"** or **"pseudomenopause"** state to cause atrophy of the ectopic endometrial tissue. This is achieved by suppressing the hypothalamic-pituitary-ovarian axis and creating a hypoestrogenic environment. ### Why Tibolone is the Correct Answer **Tibolone** is a synthetic steroid with estrogenic, progestogenic, and androgenic properties. It is primarily used as **Hormone Replacement Therapy (HRT)** in postmenopausal women to treat vasomotor symptoms and prevent osteoporosis. Because it has estrogenic activity, it would theoretically stimulate endometrial implants rather than suppress them. Therefore, it is not used as a primary treatment for endometriosis (though it may be used as "add-back therapy" alongside GnRH agonists to mitigate side effects). ### Explanation of Incorrect Options * **Medroxyprogesterone acetate (Progestins):** These cause decidualization and eventual atrophy of the endometrial tissue. They are a mainstay of treatment. * **OCPs (Combined Oral Contraceptive Pills):** These induce a "pseudopregnancy" state. They inhibit ovulation and thin the endometrial lining, reducing dysmenorrhea and pelvic pain. * **Danazol:** An attenuated androgen that inhibits the mid-cycle LH surge and creates a high-androgen, low-estrogen environment ("pseudomenopause"), leading to atrophy of the implants. ### NEET-PG High-Yield Pearls * **Gold Standard Diagnosis:** Laparoscopy (visualizing "powder-burn" or "mulberry" lesions). * **First-line Medical Management:** NSAIDs and Combined OCPs. * **Drug of Choice for Recurrence:** GnRH agonists (e.g., Leuprolide). * **Add-back Therapy:** When using GnRH agonists for >6 months, small doses of estrogen/progesterone or **Tibolone** are added to prevent bone mineral density loss and vasomotor symptoms.

Q: A 35-year-old woman complains of vaginal discomfort for 2 weeks. Physical examination reveals a scanty vaginal discharge. The fluid develops a "fishy" odor after treatment with 10% potassium hydroxide. A Pap smear taken during the pelvic examination shows squamous cells covered by coccobacilli ("clue" cells). Which of the following is the most likely etiology of vaginal discomfort in this patient?

Gardnerella vaginalis. ### Explanation The clinical presentation is a classic case of **Bacterial Vaginosis (BV)**, characterized by a shift in vaginal flora where protective *Lactobacilli* are replaced by anaerobic bacteria, most notably **Gardnerella vaginalis**. **Why Gardnerella vaginalis is correct:** The diagnosis is confirmed using **Amsel’s Criteria** (requires 3 out of 4): 1. **Thin, homogenous, grayish-white discharge:** Described here as "scanty." 2. **Positive Whiff Test:** The "fishy odor" upon adding 10% KOH is due to the release of volatile amines (putrescine and cadaverine). 3. **Clue Cells:** These are vaginal epithelial cells studded with coccobacilli, giving them a "stippled" or "shaggy" border. This is the most specific finding on microscopy/Pap smear. 4. **Vaginal pH > 4.5** (not mentioned, but implied). **Why the other options are incorrect:** * **Chlamydia trachomatis:** Typically causes mucopurulent cervicitis or pelvic inflammatory disease (PID). It is an obligate intracellular organism and does not produce clue cells or a positive whiff test. * **Herpes simplex virus (HSV):** Presents with painful, fluid-filled vesicles or shallow ulcers, often accompanied by systemic symptoms like fever. * **Human papillomavirus (HPV):** Associated with genital warts (Condyloma acuminata) or cervical dysplasia. Cytology would show **koilocytes** (cells with perinuclear halos and nuclear wrinkling), not clue cells. **NEET-PG High-Yield Pearls:** * **Treatment of Choice:** Oral Metronidazole (500 mg twice daily for 7 days). * **Pregnancy:** BV is associated with preterm labor and premature rupture of membranes (PROM). * **Nugent Scoring:** The "Gold Standard" for diagnosis (based on Gram stain morphotypes), though Amsel’s is used clinically. * **Key Distinguisher:** Unlike Trichomoniasis or Candidiasis, BV is generally **not** associated with significant vaginal inflammation (no redness or itching).

Q: A patient presented with intense vulvar pruritus, a white curd-like, cheesy vaginal discharge and vulvar erythema. Candidiasis was diagnosed. Which among the following is NOT a risk factor for vaginal candidiasis?

Hypertension. **Explanation:** Vaginal Candidiasis (Vulvovaginal Candidiasis) is a fungal infection primarily caused by *Candida albicans*. It thrives in environments where there is an alteration in the vaginal flora or a change in the host's metabolic/immune status. **Why Hypertension is the Correct Answer:** Hypertension is a vascular/hemodynamic disorder and does not alter the vaginal pH, glycogen content, or the local immune environment. There is no established pathophysiological link between high blood pressure and the overgrowth of fungal pathogens. Therefore, it is **not** a risk factor. **Analysis of Incorrect Options (Risk Factors):** * **Diabetes Mellitus:** Hyperglycemia leads to increased glycogen levels in vaginal epithelial cells. This provides an abundant food source for *Candida* and promotes its adherence to the vaginal mucosa. * **Pregnancy:** High estrogen levels during pregnancy increase vaginal glycogen content and lower the vaginal pH. Estrogen also enhances the expression of receptors for *Candida* on vaginal epithelial cells, making pregnant women highly susceptible. * **HIV Infection:** Candidiasis is an opportunistic infection. Immunosuppression (low CD4 counts) impairs the body’s ability to limit fungal colonization, leading to frequent or persistent infections. **NEET-PG High-Yield Pearls:** * **Clinical Presentation:** Characterized by "curd-like" or "cottage cheese" discharge, intense pruritus, and a vaginal pH that usually remains **normal (<4.5)**. * **Diagnosis:** Confirmed by seeing pseudohyphae and spores on a **KOH mount** (Wet smear). * **Other Risk Factors:** Broad-spectrum antibiotics (which kill protective Lactobacilli), high-dose Oral Contraceptive Pills (OCPs), and corticosteroid use. * **Drug of Choice:** Fluconazole (150 mg single dose) is the standard oral treatment; Topical Clotrimazole is preferred in pregnancy.

Question 1

What is the shape of the external os in a nulliparous female?

Accepted Answer

Circular

Answer

Transverse

Answer

Vesicular

Answer

Oval

Question 2

What is the surest sign of salpingitis?

Accepted Answer

Seropurulent discharge from the fallopian tubes

Answer

Edema of the fallopian tubes

Answer

Enlargement of the fallopian tubes

Answer

Hyperemic fallopian tubes

Question 3

All of the following can be used in the medical management of fibroid uterus EXCEPT?

Accepted Answer

Danazol

Answer

Mifepristone

Answer

NSAIDs

Answer

Leuprolide

Question 4

Pain in endometriosis is due to all except:

Accepted Answer

Retroversion of uterus

Answer

Inflammatory cytokines

Answer

Focal bleeding from endometriotic implants

Answer

Infiltration of nerves in pelvic floor

Question 5

Which type of fibroid is most commonly associated with malignancy?

Accepted Answer

Intramural

Answer

Submucosal

Answer

Ovarian

Answer

Subserosal

Question 6

Which among the following is the commonest site of genital tuberculosis in women?

Accepted Answer

Tubes

Answer

Uterus

Answer

Cervix

Answer

Vagina

Question 7

Which of the following drugs is not used for pain management in endometriosis?

Accepted Answer

Methotrexate

Answer

Oral contraceptive pills (OCPs)

Answer

Gonadotropin-releasing hormone (GnRH) agonists

Answer

Mifepristone

Question 8

All of the following are used in the treatment of endometriosis except:

Accepted Answer

Tibolone

Answer

Medroxyprogesterone acetate

Answer

OCP

Answer

Danazol

Question 9

A 35-year-old woman complains of vaginal discomfort for 2 weeks. Physical examination reveals a scanty vaginal discharge. The fluid develops a "fishy" odor after treatment with 10% potassium hydroxide. A Pap smear taken during the pelvic examination shows squamous cells covered by coccobacilli ("clue" cells). Which of the following is the most likely etiology of vaginal discomfort in this patient?

Accepted Answer

Gardnerella vaginalis

Answer

Chlamydia trachomatis

Answer

Herpes simplex virus

Answer

Human papillomavirus

Question 10

A patient presented with intense vulvar pruritus, a white curd-like, cheesy vaginal discharge and vulvar erythema. Candidiasis was diagnosed. Which among the following is NOT a risk factor for vaginal candidiasis?

Accepted Answer

Hypertension

Answer

Diabetes mellitus

Answer

Human Immunodeficiency Virus (HIV) infection

Answer

Pregnancy

Gynecological Disorders — MCQs

Gynecological Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?